Penumbra's AI-guided aspiration system and scalable platform uniquely position it as a leader in stroke and PE intervention.

Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings. The new data from the 1,178-patient FIBRONEER-ILD study ...

Introduction Outcomes after pulmonary embolism (PE) vary widely. For some patients, PE causes rapid hemodynamic collapse, whereas for others, PE is clinically inconsequential. Identifying patients at ...